ATRI - Atrion Corporation
| Previous Close | 863.50 |
| Open | 862.75 |
| Bid | 862.00 x 800 |
| Ask | 873.64 x 800 |
| Day's Range | 862.75 - 866.01 |
| 52 Week Range | 560.65 - 948.03 |
| Volume | 1,321 |
| Avg. Volume | 6,519 |
| Market Cap | 1.603B |
| Beta (3Y Monthly) | 0.27 |
| PE Ratio (TTM) | 46.91 |
| EPS (TTM) | 18.44 |
| Earnings Date | May 7, 2019 - May 13, 2019 |
| Forward Dividend & Yield | 5.40 (0.61%) |
| Ex-Dividend Date | 2019-03-14 |
| 1y Target Est | 300.00 |
- Simply Wall St.•22 days ago
Atrion Corporation (NASDAQ:ATRI) Delivered A Better ROE Than Its Industry
Want to participate in a research study? Help shape the future of investing tools and earn a $60 gift card! One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will work thro...
GuruFocus.com•29 days ago6 Stocks Beating the Market
According to the GuruFocus All-in-One Screener, the following stocks have outperformed the Standard & Poor's 500 Index over the past 12 months and were bought by gurus during the fourth quarter. Cable One Inc. (CABO) has a market cap of $5.36 billion. Warning! GuruFocus has detected 4 Warning Sign with CABO.
- Simply Wall St.•last month
Is Atrion Corporation’s (NASDAQ:ATRI) Balance Sheet A Threat To Its Future?
Zero-debt allows substantial financial flexibility, especially for small-cap companies like Atrion Corporation (NASDAQ:ATRI), as the company does not have to adhere to strict debt covenants. However, it also faces higherRead More...
- GlobeNewswire•2 months ago
Atrion Reports Results for Fourth Quarter and Full Year 2018
ALLEN, Texas, Feb. 26, 2019 -- Atrion Corporation (NASDAQ: ATRI) announced today that for the fourth quarter of 2018 revenues were $34.9 million compared to $34.0 million in.
- GlobeNewswire•2 months ago
Atrion Corporation Declares Quarterly Cash Dividend
ALLEN, Texas, Feb. 26, 2019 -- Atrion Corporation (NASDAQ: ATRI) today announced that its Board of Directors declared a quarterly dividend of $1.35 per share on its outstanding.
- GlobeNewswire•2 months ago
Investor Expectations to Drive Momentum within International Business Machines, Trex, ForeScout Technologies, Red Hat, Amedisys, and Atrion — Discovering Underlying Factors of Influence
NEW YORK, Feb. 21, 2019 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.
- Simply Wall St.•2 months ago
Have Insiders Been Selling Atrion Corporation (NASDAQ:ATRI) Shares?
Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! We often see insiders buying up shares Read More...
- Simply Wall St.•3 months ago
Should You Like Atrion Corporation’s (NASDAQ:ATRI) High Return On Capital Employed?
Today we'll evaluate Atrion Corporation (NASDAQ:ATRI) to determine whether it could have potential as an investment idea. To be precise, we'll consider its Return On Capital Employed (ROCE), as that Read More...
- Simply Wall St.•4 months ago
Does Atrion Corporation’s (NASDAQ:ATRI) CEO Pay Compare Well With Peers?
In 2011 David Battat was appointed CEO of Atrion Corporation (NASDAQ:ATRI). This report will, first, examine the CEO compensation levels in comparison to CEO compensation at companies of similar size. Read More...
- Associated Press•5 months ago
Atrion: 3Q Earnings Snapshot
The Allen, Texas-based company said it had profit of $4.96 per share. The medical device maker posted revenue of $39.3 million in the period. Atrion shares have increased 13 percent since the beginning ...
- GlobeNewswire•5 months ago
Atrion Reports Third Quarter Results
ALLEN, Texas, Nov. 09, 2018 -- Atrion Corporation (NASDAQ: ATRI) today announced that for the third quarter ended September 30, 2018 revenues totaled $39.3 million, up from.
- Simply Wall St.•5 months ago
Do Insiders Own Lots Of Shares In Atrion Corporation (NASDAQ:ATRI)?
Every investor in Atrion Corporation (NASDAQ:ATRI) should be aware of the most powerful shareholder groups. Large companies usually have institutions as shareholders, and we usually see insiders owning shares in Read More...
- Simply Wall St.•6 months ago
Does Atrion Corporation’s (NASDAQ:ATRI) PE Ratio Warrant A Buy?
This article is intended for those of you who are at the beginning of your investing journey and want to begin learning about how to value company based on its Read More...
- Simply Wall St.•7 months ago
Can Atrion Corporation’s (NASDAQ:ATRI) ROE Continue To Surpass The Industry Average?
This analysis is intended to introduce important early concepts to people who are starting to invest and want to learn about Return on Equity using a real-life example. Atrion CorporationRead More...
- Associated Press•8 months ago
Atrion: 2Q Earnings Snapshot
On a per-share basis, the Allen, Texas-based company said it had net income of $4.74. Earnings, adjusted for pretax gains, were $4.70 per share. The medical device maker posted revenue of $38.8 million ...
- ACCESSWIRE•11 months ago
Blog Exposure - FDA Approved Expanded Indications for TransEnterix's Senhance Surgical System
LONDON, UK / ACCESSWIRE / May 31, 2018 / If you want access to our free research report on TransEnterix, Inc. (NYSE: TRXC), all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/?symbol=TRXC as the Company's latest news hit the wire. On May 29, 2018, the Company announced that the US Food and Drug Administration (FDA) has granted 510(k) clearance for expanded indications of the Company's Senhance Surgical System for laparoscopic inguinal hernia and laparoscopic cholecystectomy (gallbladder removal) surgery.
- Simply Wall St.•11 months ago
Where Atrion Corporation (NASDAQ:ATRI) Stands In Terms Of Earnings Growth Against Its Industry
Assessing Atrion Corporation’s (NASDAQ:ATRI) past track record of performance is a useful exercise for investors. It allows us to understand whether the company has met or exceed expectations, which isRead More...
